IP Library › Patent Application 63569684
Patent Application Provisional
App. No. 63/569,684 · Confirmation No. 2869

USE OF REBOXETINE TO TREAT NARCOLEPSY

Inventor: Herriot Tabuteau
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2024-09-05 PETDEC Petition Decision 2 View
2024-08-29 APP.FILE.REC Filing Receipt 3 View
2024-08-15 WFEE Fee Worksheet (SB06) 1 View
2024-04-26 ADS Application Data Sheet 8 View
2024-04-26 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-04-26 SES.LOSS Notification of loss of entitlement to small entity status 2 View
2024-04-03 APP.FILE.REC Filing Receipt 3 View
2024-04-03 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2024-04-03 SES.LOSS.PC Notification of loss of entitlement to small entity status via PC 1 View
2024-03-25 SPEC Specification — View
2024-03-25 DRW Drawings-only black and white line drawings 5 View
2024-03-25 ADS Application Data Sheet 8 View
2024-03-25 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-03-25 APPENDIX Appendix to the specification 25 View
2024-03-25 SPEC Specification 101 View
2024-03-25 CLM Claims 3 View
2024-03-25 ABST Abstract 1 View
2024-03-25 N417.PYMT Electronic Fee Payment 2 View
2024-03-25 APPENDIX.SUPP Appendix to the specification — View
2024-03-25 APPENDIX Appendix to the specification 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/569,684
Filed
2024-03-25